United States · Series B startup

Who invested in Novome Biotechnologies

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$44Mraised across 1 round since 2022, from 1 source

Latest round
Series B, $44MSept 2022
Investors
5
See who backed them

The rounds

  1. Sept 2022

Founders and team

From the SEC filings it signed: 1 on the team.

  • Weston WhitakerExecutive Officer, Director, Promoteri

On the board, as filediElizabeth StanleySamuel SmitsWilliam DeLoache

Everyone who backed them

Tengxun TouziVC firm1round
DCVCVC firm1round
5AM VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Novome Biotechnologies

Who invested in Novome Biotechnologies?

Novome Biotechnologies's investors include National Science Foundation, Tengxun Touzi, DCVC, 5AM Ventures and Alexandria Venture Investments.

How much has Novome Biotechnologies raised?

Novome Biotechnologies has raised $44M across 1 round since 2022.

When did Novome Biotechnologies last raise?

Novome Biotechnologies's most recent round was a Series B of $44M in Sept 2022.

What was Novome Biotechnologies's biggest round?

Its most recent round, $44M in Sept 2022, is also its largest on record.

Who backed Novome Biotechnologies first?

Novome Biotechnologies's first round on record, in Sept 2022, was backed by National Science Foundation, Tengxun Touzi and DCVC and 2 others.

What stage is Novome Biotechnologies at?

Novome Biotechnologies's latest named round is a Series B, in Sept 2022.

Where is Novome Biotechnologies based?

Novome Biotechnologies is based in the United States.

Companies like Novome Biotechnologies

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.